You have no items in your shopping cart.
In the era of pandemics, lipid nanoparticles have emerged as critical components in mRNA vaccine formulations, exemplified by the success of COVID-19 vaccines. These nanoparticles facilitate efficient cellular uptake, ensuring the translation of viral antigens and prompting robust immune responses.
Articles & Research Reviews
Featured Review
.png)
Read more >
Nanotechnology
Read more >
Virology
Read more >
Viral Antigens
Read more >
Assay Kits
Read more >
Recombinant Proteins
Read more >
Epidemiology
Read more >
Drug Delivery
Read more >
Virology
Read more >
Infectious Disease
Read more >
Microbiology
Read more >
Infectious Disease
Read more >
Advances in mRNA Technology
The success of COVID-19 mRNA vaccines has invigorated interest in leveraging mRNA for diverse clinical purposes. Early trials are investigating therapeutic vaccination strategies against oncology targets, infectious pathogens, and autoimmune disorders.
Virus-like Particles
VLPs are nanoscale particles that look like viruses but are non-infectious. Composed of self-assembling viral structural proteins, they present high-density conformational epitopes to stimulate strong B-cell and T-cell responses.
Coronavirus
In our societies where global travel has become the norm, the large-scale transmission of infectious respiratory diseases is of ever-increasing concern. Discover essential reagents for coronavirus surveillance and vaccine discovery.
Novel Spike Protein
A variant carrying a D614G mutation in the Spike (S) protein of SARS-CoV-2 emerged early in the pandemic. Explore structural shifts in viral infectivity, ACE2 receptor affinity, and neutralizing antibody evasion.
Covid-19 ELISA Assays
Novel COVID-19 IgG and IgM ELISA assays providing sensitive and reliable measurements of specific antibodies against SARS-CoV-2 antigens in human serum and plasma samples.
Variant Spike Proteins
Isolated Spike Proteins from emerging COVID-19 lineages are available from Biorbyt, manufactured on a proprietary mammalian protein expression platform to ensure authentic glycosylation and folding.
Coronavirus Variants
At the beginning of 2003, the first severe coronavirus with pandemic potential emerged from China and spread globally. Trace the evolutionary trajectory of SARS-CoV, MERS-CoV, and SARS-CoV-2 strains.
Understanding Lipid Nanoparticles
Lipid nanoparticles represent a revolutionary class of drug delivery systems, designed to encapsulate and transport fragile nucleic acid payloads—including mRNA, siRNA, and CRISPR sgRNA—into target cells with precision.
Decoding Nipah Virus
Investigating the mechanisms behind a 40–75% fatality rate and tracking the latest breakthroughs in global vaccines and antiviral treatments targeting this emerging pathogen.
Ebola Virus Research Hub
Explore comprehensive tools and resources for Ebola virus research, from structural protein analysis to therapeutic antibody discovery and diagnostic assay development.
Outer Membrane Proteins of Bacteria
Exploring Gram-negative bacterial envelope architecture, β-barrel OMP biogenesis, and targeted reagents critical for evaluating subunit vaccine candidates.
Hantavirus Research Reagents
Explore comprehensive tools for Hantavirus research, including specific antibodies, recombinant proteins, and assay kits to advance the study of viral pathogenesis and diagnostic development.